Philip L Smith Selected Research

Philip L Smith Research Topics

Disease

7	Malaria 07/2020 - 04/2005
7	Obstructive Sleep Apnea 05/2017 - 03/2003
6	Sleep Apnea Syndromes (Sleep Apnea) 05/2014 - 03/2002
5	Obesity 05/2012 - 09/2005
4	Infections 01/2020 - 11/2011
4	Body Weight (Weight, Body) 01/2020 - 09/2011
4	Apnea 09/2011 - 11/2006
4	Hypoxia (Hypoxemia) 09/2011 - 10/2003
3	Cutaneous Leishmaniasis 10/2013 - 01/2009
2	Morbid Obesity 01/2016 - 05/2014
2	Insulin Resistance 01/2016 - 10/2003
2	Airway Obstruction (Choking) 05/2014 - 07/2007
2	Inflammation (Inflammations) 01/2014 - 10/2007
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2014 - 01/2010
2	Weight Loss (Weight Reduction) 05/2012 - 09/2011
2	Atherosclerosis 06/2007 - 02/2007
1	COVID-19 01/2020
1	Parasitemia 01/2020
1	Vivax Malaria 10/2019
1	Glucosephosphate Dehydrogenase Deficiency 10/2018
1	Snoring 05/2017
1	Falciparum Malaria (Plasmodium falciparum Malaria) 04/2015
1	Respiratory Insufficiency (Respiratory Failure) 05/2014
1	Fatigue 01/2014
1	Sleepiness 01/2014
1	Necrosis 01/2014
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2014
1	HIV Infections (HIV Infection) 01/2014
1	Visceral Leishmaniasis (Kala Azar) 10/2013
1	Heart Failure 09/2011
1	Neglected Diseases 01/2009
1	Dyslipidemias (Dyslipidemia) 06/2007
1	Hyperglycemia 04/2007
1	Multiple Endocrine Neoplasia Type 2b (MEN 3) 11/2006
1	Fatty Liver 11/2005
1	Hyperlipidemias (Hyperlipidemia) 09/2005
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2003
1	Parkinson Disease (Parkinson's Disease) 02/2003

Drug/Important Bio-Agent (IBA)

5	LeptinIBA 05/2014 - 10/2003
4	Pharmaceutical PreparationsIBA 07/2020 - 10/2013
4	Primaquine FDA Link 10/2019 - 07/2015
4	CholesterolIBA 10/2007 - 09/2005
3	Chloroquine (Aralen)FDA LinkGeneric 07/2020 - 04/2015
3	Insulin (Novolin)FDA Link 01/2016 - 10/2003
3	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 03/2002
3	Oxygen (Dioxygen)IBA 09/2011 - 03/2002
3	LipidsIBA 02/2007 - 09/2005
2	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 10/2013 - 02/2013
2	Gentamicins (Gentamicin)FDA LinkGeneric 10/2013 - 02/2013
1	Genetic Markers (Genetic Marker)IBA 07/2020
1	plasmepsin (plasmepsin I)IBA 07/2020
1	Exonucleases (3' 5' Exonuclease)IBA 07/2020
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2020
1	Ivermectin (Mectizan)FDA Link 01/2020
1	piperaquineIBA 10/2018
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 10/2018
1	Matrix Metalloproteinases (MMPs)IBA 10/2018
1	artenimol (dihydroartemisinin)IBA 10/2018
1	VaccinesIBA 01/2017
1	Antimalarials (Antimalarial Agents)IBA 01/2016
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2016
1	tafenoquineIBA 07/2015
1	Mefloquine (Lariam)FDA LinkGeneric 04/2015
1	InterleukinsIBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 09/2011
1	Nonesterified Fatty Acids (NEFA)IBA 09/2011
1	AdiponectinIBA 09/2011
1	GhrelinIBA 09/2011
1	CytokinesIBA 09/2011
1	Interleukin-6 (Interleukin 6)IBA 09/2011
1	Leptin ReceptorsIBA 09/2011
1	Ointments (Pastes)IBA 01/2009
1	AminoglycosidesIBA 01/2009
1	Oxyhemoglobins (Oxyhemoglobin)IBA 07/2007
1	LDL CholesterolIBA 06/2007
1	EnzymesIBA 06/2007
1	Lipoproteins (Lipoprotein)IBA 06/2007
1	stearoyl-coenzyme A (stearoyl-CoA)IBA 06/2007
1	GlycogenIBA 04/2007
1	Triglycerides (Triacylglycerol)IBA 04/2007
1	cycloguanilIBA 04/2005
1	Folic Acid AntagonistsIBA 04/2005
1	Blood Glucose (Blood Sugar)IBA 10/2003
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 02/2003
1	Tolcapone (Tasmar)FDA Link 02/2003

Therapy/Procedure

5	Continuous Positive Airway Pressure 05/2017 - 03/2003
3	Therapeutics 01/2020 - 01/2009
3	Highly Active Antiretroviral Therapy (HAART) 01/2014 - 01/2010
2	Bariatric Surgery 05/2014 - 09/2011
2	Device Removal (Removal, Device) 02/2014 - 11/2011
2	Cannula 07/2009 - 07/2007
1	Traction 02/2010
1	Airway Management 02/2010
1	Tracheostomy 11/2006